FARRAGUT PARTNERS LLP

Lobbying for DEXCOM, INC. · Medical Device Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Medicare/Medicaid

General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.